Zoetis | ZTS - Pre Tax Profit


Zoetis reported $758M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
Align Technology USD 148.69M 193K Jun/2026
Bayer EUR 321M 2.67B Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Charles River Laboratories USD -29.94M 264.16M Mar/2026
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Dentsply International USD -42M 105M Mar/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Henry Schein USD 137M 13M Jun/2026
Idexx Laboratories USD 417.22M 61.78M Jun/2026
Illumina USD 260M 103M Jun/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
J&J USD 8.66B 839M Jun/2026
Laboratory Of America USD 8.61B 121.8M Jun/2026
Merck USD -3.53B 6.95B Mar/2026
Neogen USD -20.3M 48.3M Dec/2025
Pacira USD 5M 4.43M Mar/2026
Perrigo USD 105.4M 513.9M Jun/2026
Pfizer USD -653M 5.84B Jun/2026
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Sanofi EUR 837M 1.17B Jun/2026
Sanofi EUR 2B 3.16B Mar/2026
Zoetis USD 758M 3M Mar/2026